OBJECTIVES: The understanding of changes in comorbidity might improve the management of upper gastrointestinal bleeding (UGIB); such changes might not be detectable in short-term studies. We aimed to study UGIB mortality as adjusted for comorbidity and the trends in risk scores over a 14-year period. METHODS: Patients presenting with UGIB to a single institution, 1996-2010, were assessed. Those with multiple comorbidities were managed in a multi-disciplinary care unit since 2000. Trends with time were assessed using logistic regression, including those for Charlson comorbidity score, the complete Rockall score and 30-day mortality. RESULTS: 2669 patients were included. The Charlson comorbidity score increased significantly with time: the odds of a high (3+) score increasing at a relative rate of 4.4% a year (OR 1.044; p<0.001). The overall 30-day mortality was 4.9% and inpatient mortality was 7.1%; these showed no relationship with time. When adjusted for the increasing comorbidity, the odds of death decreased significantly at a relative rate of 4.5% per year (p=0.038). After the introduction of multi-disciplinary care, the raw mortality OR was 0.680 (p=0.08), and adjusted for comorbidity it was 0.566 (p=0.013). CONCLUSIONS: 30-day mortality decreased when adjusted for the rising comorbidity in UGIB; whether this is related to the introduction of multi-disciplinary care needs to be considered.
OBJECTIVES: The understanding of changes in comorbidity might improve the management of upper gastrointestinal bleeding (UGIB); such changes might not be detectable in short-term studies. We aimed to study UGIB mortality as adjusted for comorbidity and the trends in risk scores over a 14-year period. METHODS:Patients presenting with UGIB to a single institution, 1996-2010, were assessed. Those with multiple comorbidities were managed in a multi-disciplinary care unit since 2000. Trends with time were assessed using logistic regression, including those for Charlson comorbidity score, the complete Rockall score and 30-day mortality. RESULTS: 2669 patients were included. The Charlson comorbidity score increased significantly with time: the odds of a high (3+) score increasing at a relative rate of 4.4% a year (OR 1.044; p<0.001). The overall 30-day mortality was 4.9% and inpatient mortality was 7.1%; these showed no relationship with time. When adjusted for the increasing comorbidity, the odds of death decreased significantly at a relative rate of 4.5% per year (p=0.038). After the introduction of multi-disciplinary care, the raw mortality OR was 0.680 (p=0.08), and adjusted for comorbidity it was 0.566 (p=0.013). CONCLUSIONS: 30-day mortality decreased when adjusted for the rising comorbidity in UGIB; whether this is related to the introduction of multi-disciplinary care needs to be considered.
Authors: C Mel Wilcox; Jeroan Allison; Keith Benzuly; Marie Borum; Byron Cryer; Tilo Grosser; Richard Hunt; Uri Ladabaum; Angel Lanas; Harold Paulus; Carol Regueiro; Robert S Sandler; Lee Simon Journal: Clin Gastroenterol Hepatol Date: 2006-07-31 Impact factor: 11.382
Authors: A Lanas; L A García-Rodríguez; M Polo-Tomás; M Ponce; E Quintero; M A Perez-Aisa; J P Gisbert; L Bujanda; M Castro; M Muñoz; M D Del-Pino; S Garcia; X Calvet Journal: Aliment Pharmacol Ther Date: 2011-01-05 Impact factor: 8.171
Authors: Alan N Barkun; Marc Bardou; Ernst J Kuipers; Joseph Sung; Richard H Hunt; Myriam Martel; Paul Sinclair Journal: Ann Intern Med Date: 2010-01-19 Impact factor: 25.391
Authors: L Camellini; A Merighi; C Pagnini; F Azzolini; S Guazzetti; A Scarcelli; F Manenti; G P Rigo Journal: Dig Liver Dis Date: 2004-04 Impact factor: 4.088
Authors: David S Sanders; Mike J Perry; Simon G W Jones; Elaine McFarlane; Alan G Johnson; Dermot C Gleeson; Alan J Lobo Journal: Eur J Gastroenterol Hepatol Date: 2004-05 Impact factor: 2.566
Authors: Cosmos L T Guo; Sunny H Wong; Louis H S Lau; Rashid N S Lui; Joyce W Y Mak; Raymond S Y Tang; Terry C F Yip; William K K Wu; Grace L H Wong; Francis K L Chan; James Y W Lau; Joseph J Y Sung Journal: Gut Date: 2021-09-21 Impact factor: 31.793